Structure-Function Relationships in the Rodent Streptozotocin-Induced Model for Diabetic Retinopathy: A Systematic

Inesa Lelyte1,2, Zubair Ahmed2,3, Simon Kaja4,5

  • 1Research and Development Division, Experimentica Ltd., Kuopio, Finland.

Insights

The streptozotocin (STZ)-induced rodent model for diabetic retinopathy (DR) lacks standardized readouts. Electroretinography (ERG) is the most consistent functional measure, but high bias risk necessitates cautious interpretation in preclinical drug discovery.

Area of Science:

  • Ophthalmology
  • Preclinical Research
  • Diabetology

Background:

  • The streptozotocin (STZ)-induced rodent model is widely used for diabetic retinopathy (DR) research.
  • Significant variability exists in experimental readouts and standardization within this model.
  • This limits the reliability and comparability of preclinical drug discovery findings.

Purpose of the Study:

  • To systematically review and compare functional and structural readouts in STZ-induced DR rodent models.
  • To identify the most effective readouts for assessing DR progression and treatment efficacy.
  • To provide recommendations for improving future study designs and reducing bias.

Main Methods:

  • Systematic literature search of PubMed and EMBASE databases.
  • Inclusion of studies reporting both functional and structural readouts in STZ-induced DR models.
  • Assessment of risk of bias and qualitative analysis of selected studies.

Main Results:

  • Twenty-one studies using rats or mice (2-24 weeks) were included.
  • Electroretinography (ERG) consistently showed reduced wave amplitudes across studies.
  • Structural analyses revealed retinal thinning, vascular changes, and inflammation; however, high risk of bias was noted in all studies.

Conclusions:

  • Electroretinography (ERG) is the most reliable functional readout in STZ-induced DR models.
  • Inconsistent hyperglycemia criteria and high risk of bias necessitate careful interpretation of current findings.
  • Standardization of readouts and improved study conduct are crucial for advancing DR preclinical research.